[1]
Mozzan, W.A.A.J. et al. 2025. Generation and Characterization of a Novel Anti-IL-17A Monoclonal Antibody for the Treatment of Psoriatic Arthritis. Trends in Pharmaceutical Biotechnology. 3, 1 (Jun. 2025), 49–63. DOI:https://doi.org/10.57238/tpb.2025.153196.1027.